Literature DB >> 33030822

Clinical manifestations and long-term outcomes in three ocular rosacea cases treated at a highly specialized hospital in southeast México

Fiona Xacur-García1, Rodrigo Díaz-Novelo2, Linnete Herrera-David3, Paulina Moreno-Arjona4, Nina Méndez-Domínguez5.   

Abstract

Rosacea is a chronic skin disorder that has been associated with unspecific etiological factors and diverse systemic manifestations. Cutaneous rosacea usually evolves to ocular rosacea in 6 to 72% of patients. In the absence of specific criteria to characterize this pathology, ocular rosacea can mean a diagnostic challenge. To strengthen early diagnostic suspicion, we present three cases of patients with different clinical evolution who had in common diagnostic delay resulting in severe manifestations and extensive ocular damage.

Entities:  

Keywords:  Rosacea; eye diseases; diagnostic techniques; ophthalmological; prognosis; transplantation

Year:  2020        PMID: 33030822      PMCID: PMC7666856          DOI: 10.7705/biomedica.5001

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  6 in total

Review 1.  A review of the diagnosis and treatment of rosacea.

Authors:  Noah Scheinfeld; Thomas Berk
Journal:  Postgrad Med       Date:  2010-01       Impact factor: 3.840

Review 2.  [Rosacea].

Authors:  D Barco; A Alomar
Journal:  Actas Dermosifiliogr       Date:  2008-05

Review 3.  Rosacea.

Authors:  Esther J van Zuuren
Journal:  N Engl J Med       Date:  2017-11-02       Impact factor: 91.245

4.  Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline.

Authors:  Aysegul Arman; Duriye Deniz Demirseren; Tamer Takmaz
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

Review 5.  Is rosacea a systemic disease?

Authors:  Uwe Wollina
Journal:  Clin Dermatol       Date:  2019-07-31       Impact factor: 3.541

6.  Therapeutical Management for Ocular Rosacea.

Authors:  Gloria López-Valverde; Elena Garcia-Martin; José Manuel Larrosa-Povés; Vicente Polo-Llorens; Luis E Pablo-Júlvez
Journal:  Case Rep Ophthalmol       Date:  2016-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.